Australian-led mRNA cancer vaccine trial cuts melanoma return risk by 42 per cent

Australian scientists are leading a breakthrough in a world-first cancer vaccine, which has shown signs of drastically reducing the risk of melanoma coming back after surgery.

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.themercury.com.au)